Leidos Awarded CDC’s National Healthcare Safety Network Modernization Contract
Leidos (NYSE:LDOS) has been awarded the National Healthcare Safety Network (NHSN) Development, Maintenance, Support, and Modernization contract by the CDC's National Center for Emerging and Zoonotic Infectious Diseases. The contract, valued at $51 million over five years, involves Leidos leveraging its data management and mission software expertise to maintain and enhance the NHSN platform.
NHSN is a critical system that serves nearly all U.S. healthcare facilities, including hospitals, nursing homes, and dialysis centers. It facilitates electronic messaging from health records, informs infection prevention, monitors healthcare system capacity, tracks vaccination uptake, and helps prevent the spread of threats like COVID-19 and antimicrobial-resistant infections.
Leidos will work on advancing and modernizing the NHSN application, which currently empowers over 160,000 users at more than 38,000 facilities with reliable data, driving improvements in patient outcomes and system efficiency.
Leidos (NYSE:LDOS) ha ricevuto l'incarico per lo sviluppo, la manutenzione, il supporto e la modernizzazione della National Healthcare Safety Network (NHSN) dal National Center for Emerging and Zoonotic Infectious Diseases dei CDC. Il contratto, del valore di 51 milioni di dollari per cinque anni, prevede che Leidos utilizzi la propria esperienza nella gestione dei dati e nel software per le missioni per mantenere e migliorare la piattaforma NHSN.
NHSN è un sistema fondamentale che serve quasi tutte le strutture sanitarie degli Stati Uniti, tra cui ospedali, case di cura e centri di dialisi. Facilita la messaggistica elettronica dai registri sanitari, informa la prevenzione delle infezioni, monitora la capacità del sistema sanitario, traccia l'adesione alle vaccinazioni e aiuta a prevenire la diffusione di minacce come COVID-19 e infezioni resistente agli antimicrobici.
Leidos lavorerà per avanzare e modernizzare l'applicazione NHSN, che attualmente supporta oltre 160.000 utenti in più di 38.000 strutture con dati affidabili, contribuendo a migliorare i risultati dei pazienti e l'efficienza del sistema.
Leidos (NYSE:LDOS) ha sido adjudicada el contrato para el desarrollo, mantenimiento, soporte y modernización de la National Healthcare Safety Network (NHSN) por el Centro Nacional de Enfermedades Infecciosas Emergentes y Zoonóticas de los CDC. El contrato, valorado en 51 millones de dólares durante cinco años, implica que Leidos aproveche su experiencia en gestión de datos y software de misión para mantener y mejorar la plataforma NHSN.
NHSN es un sistema crítico que sirve a casi todas las instalaciones de salud en EE.UU., incluidas hospitales, casas de cuidado y centros de diálisis. Facilita la mensajería electrónica de los registros de salud, informa sobre la prevención de infecciones, monitorea la capacidad del sistema de salud, rastrea la tasa de vacunación y ayuda a prevenir la propagación de amenazas como el COVID-19 y las infecciones resistentes a los antimicrobianos.
Leidos trabajará en la evolución y modernización de la aplicación NHSN, que actualmente capacita a más de 160,000 usuarios en más de 38,000 instalaciones con datos confiables, impulsando mejoras en los resultados de los pacientes y la eficiencia del sistema.
Leidos (NYSE:LDOS)는 CDC의 국가 신흥 및 동물 감염 질병 센터(National Center for Emerging and Zoonotic Infectious Diseases)로부터 국가 의료 안전 네트워크(NHSN) 개발, 유지 보수, 지원 및 현대화 계약을 수여받았습니다. 이 계약은 5년 동안 5,100만 달러의 가치가 있으며, Leidos는 데이터 관리 및 미션 소프트웨어 전문 지식을 활용하여 NHSN 플랫폼을 유지하고 개선하게 됩니다.
NHSN은 미국의 거의 모든 의료 시설, 즉 병원, 요양원 및 투석 센터를 위한 중요한 시스템입니다. 건강 기록의 전자 메시징을 촉진하고, 감염 예방에 대한 정보를 제공하며, 의료 시스템 용량을 모니터링하고, 백신 접종 현황을 추적하며, COVID-19 및 항생제 내성 감염과 같은 위협의 확산을 방지하는 데 도움을 줍니다.
Leidos는 NHSN 애플리케이션의 발전과 현대화 작업을 수행할 것이며, 현재는 38,000개 이상의 시설에서 160,000명 이상의 사용자에게 신뢰할 수 있는 데이터를 제공하여 환자 결과 개선과 시스템 효율성을 향상시키고 있습니다.
Leidos (NYSE:LDOS) a été attribué le contrat de développement, de maintenance, de support et de modernisation du National Healthcare Safety Network (NHSN) par le Centre national des CDC pour les maladies infectieuses émergentes et zoonotiques. Le contrat, d'une valeur de 51 millions de dollars sur cinq ans, implique que Leidos utilise son expertise en gestion des données et en logiciel de mission pour maintenir et améliorer la plateforme NHSN.
NHSN est un système essentiel qui dessert quasiment tous les établissements de santé aux États-Unis, y compris les hôpitaux, les maisons de soins et les centres de dialyse. Il facilite l'envoi de messages électroniques issus des dossiers de santé, informe sur la prévention des infections, surveille la capacité du système de santé, suit l'adhésion aux vaccinations et aide à prévenir la propagation de menaces telles que COVID-19 et les infections résistantes aux antimicrobiens.
Leidos travaillera à l'avancement et à la modernisation de l'application NHSN, qui permet actuellement à plus de 160 000 utilisateurs dans plus de 38 000 établissements d'accéder à des données fiables, contribuant à améliorer les résultats pour les patients et l'efficacité du système.
Leidos (NYSE:LDOS) wurde vom National Center for Emerging and Zoonotic Infectious Diseases der CDC mit dem Vertrag zur Entwicklung, Pflege, Unterstützung und Modernisierung des National Healthcare Safety Network (NHSN) beauftragt. Der Vertrag hat einen Wert von 51 Millionen Dollar über fünf Jahre und beinhaltet, dass Leidos seine Expertise im Datenmanagement und bei Missionssoftware nutzt, um die NHSN-Plattform zu erhalten und zu verbessern.
NHSN ist ein kritisches System, das nahezu alle Gesundheitsstätten in den USA bedient, darunter Krankenhäuser, Pflegeeinrichtungen und Dialysezentren. Es erleichtert die elektronische Nachrichtenübermittlung aus Gesundheitsakten, informiert über Infektionsprävention, überwacht die Kapazität des Gesundheitssystems, verfolgt die Impfquote und hilft, die Verbreitung von Bedrohungen wie COVID-19 und antimikrobiell resistenten Infektionen zu verhindern.
Leidos wird an der Weiterentwicklung und Modernisierung der NHSN-Anwendung arbeiten, die derzeit über 160.000 Benutzer in mehr als 38.000 Einrichtungen mit zuverlässigen Daten versorgt und Verbesserungen bei den Patientenergebnissen und der Systemeffizienz vorantreibt.
- Secured a $51 million contract over five years with the CDC
- Continuation and expansion of long-standing partnership with CDC since 2003
- Opportunity to modernize and advance a critical healthcare data platform
- Serves nearly all U.S. healthcare facilities, indicating wide market reach
- None.
Insights
RESTON, VA / ACCESSWIRE / October 1, 2024 /Leidos (NYSE:LDOS), a Fortune® 500 innovation company, was recently awarded the National Healthcare Safety Network (NHSN) Development, Maintenance, Support, and Modernization contract by the Centers for Disease Control and Prevention's (CDC's) National Center for Emerging and Zoonotic Infectious Diseases. Leidos will leverage its data management and mission software expertise to continue delivering a secure NHSN platform, including the necessary support applications and inputs from partnering federal agencies. The contract has a total value of
"NHSN is a critical cornerstone in enhancing patient safety and healthcare delivery across the U.S.," said Liz Porter, Leidos Health & Civil Sector president. "Since the inception of NHSN in 2003, our collaboration with the CDC has empowered over 160,000 users at more than 38,000 facilities with reliable and actionable data. Our combined efforts ensure the secure transmission of healthcare data across evolving sites of care, driving improvements in patient outcomes and fostering system modernization and efficiency."
Leidos will work to continue to advance and modernize the NHSN application. NHSN facilitates electronic messaging directly from electronic health records; informs rapid, tailored infection prevention; and allows decision-makers to monitor healthcare system capacity. Additionally, the platform tracks vaccination uptake in healthcare settings, monitors blood safety errors, and helps prevent the spread of emerging and enduring threats, such as COVID-19, healthcare associated infections, and antimicrobial-resistant infections.
The NHSN serves nearly all U.S. hospitals, nursing homes, dialysis facilities, and ambulatory surgery centers. This contract will extend Leidos' support in providing the critical data necessary to understand the success of prevention efforts and practices in healthcare, ultimately determining the quality and safety of care delivered in U.S. healthcare facilities.
View additional multimedia and more ESG storytelling from Leidos on 3blmedia.com.
Contact Info:
Spokesperson: Leidos
Website: https://www.3blmedia.com/profiles/leidos
Email: info@3blmedia.com
SOURCE: Leidos
View the original press release on accesswire.com
FAQ
What is the value and duration of the NHSN contract awarded to Leidos (LDOS)?
How many facilities and users does the NHSN platform currently serve?
What types of healthcare facilities does the NHSN platform cover?
What are some key functions of the NHSN platform that Leidos (LDOS) will be maintaining and modernizing?
